David Bruckner to Direct Smile 3 as Paramount Expands Its Flagship Horror Franchise

Paramount Pictures has officially tapped acclaimed horror filmmaker David Bruckner to helm the third installment of the highly successful Smile franchise. The announcement marks a significant transition for the series, as Bruckner steps into the director’s chair to build upon the foundation laid by series creator Parker Finn. While Finn, who wrote and directed both 2022’s original Smile and its 2024 sequel, is stepping back from the director’s role, he remains deeply embedded in the project as a producer, having developed and pitched the structural framework for the third film. The script for the upcoming project will be penned by Nick Antosca, an accomplished writer and producer known for his work on genre-defining television such as Channel Zero and the Hulu miniseries The Act.

A New Vision for a Growing Franchise

David Bruckner’s appointment signals a strategic move by Paramount to maintain the intensity and critical appeal of the Smile universe while infusing it with a fresh creative perspective. Bruckner is no stranger to the demands of modern horror; he garnered significant industry attention for his 2022 reimagining of the Hellraiser franchise for Hulu, which was praised for its dark, atmospheric aesthetic and commitment to the series’ visceral roots. His portfolio also includes the acclaimed psychological horror film The Night House and the atmospheric creature feature The Ritual.

Industry analysts note that bringing in an established genre auteur like Bruckner is a calculated effort to preserve the "prestige horror" quality that allowed the first two films to transcend traditional genre tropes. By retaining Parker Finn as a producer, the studio ensures narrative continuity, maintaining the core DNA of the entity—a parasitic, trauma-based curse that manifests through a terrifying, wide-eyed grin.

Chronology of the Smile Phenomenon

The trajectory of the Smile franchise has been nothing short of a modern horror success story.

• September 2022: The original Smile, directed by Parker Finn, debuts in theaters. Based on his 2020 short film Laura Hasn’t Slept, the feature film became a cultural phenomenon, fueled by viral marketing campaigns that featured actors sitting in the background of live television broadcasts with unnerving, static smiles.
• Late 2022: Smile concludes its theatrical run as the highest-grossing original horror film of 2022, signaling a major win for Paramount’s strategy of prioritizing original IP over established legacy sequels.
• March 2023: Parker Finn signs a comprehensive first-look deal with Paramount Pictures, solidifying his role as the studio’s primary architect for high-concept horror.
• October 2024: Smile 2 is released, expanding the mythology by focusing on a global pop star navigating the curse, further cementing the franchise’s commercial viability.
• October 2026: Paramount officially announces the development of Smile 3 with David Bruckner attached to direct, setting the stage for the next chapter in the series.

Data and Market Impact

The financial success of the Smile franchise provides the necessary context for the aggressive development of a third film. With a production budget of approximately $17 million, the first film earned over $217 million globally, a staggering return on investment that caught industry executives by surprise. The success of the second entry continued this trend, proving that the concept was not a one-off hit but a durable franchise capable of sustained box office dominance.

To date, the two films have grossed a combined total exceeding $350 million worldwide. This consistent performance has elevated Smile to the status of a flagship franchise for Paramount, comparable to their historical reliance on properties like A Quiet Place. The decision to proceed with a third film so quickly after the release of the second reflects both the studio’s confidence in the brand and the appetite of the global horror audience for high-concept, supernatural narratives.

Strategic Implications for Paramount

The involvement of Nick Antosca as the screenwriter is a vital component of this transition. Antosca’s background in episodic horror provides a specific skill set for building world-lore, which is essential as the franchise moves away from the origin-story focus of the first film and into a broader, potentially more expansive mythology.

Parker Finn’s continued involvement as a producer is intended to mitigate the risks often associated with director swaps in long-running horror series. In post-release interviews regarding the second film, Finn emphasized that while he wanted the franchise to evolve, he remained protective of its core identity. "There’s a lot of really exciting places that Smile could go to from here," Finn stated. "I love this idea that potential future iterations of Smile could go bigger and more off the rails and even crazier and more unhinged. But, for me, what’s important about Smile is that there is a real human, character-driven, intimate nature to the storytelling."

This philosophy appears to be the guiding principle for the upcoming production. The studio is looking to balance "unhinged" horror set pieces with the grounded, trauma-informed storytelling that made the franchise a critical darling.

Bruckner’s Busy Pipeline

David Bruckner’s schedule suggests that he is currently one of the most sought-after directors in the horror landscape. Beyond his work on Smile 3, he is actively developing several high-profile projects:

1. The Caretaker: An adaptation of the book by Marcus Kliewer for Universal Pictures, which is set to star Sydney Sweeney.
2. Mice: A project currently in development for A24, further aligning his career with the "elevated horror" movement championed by the studio.
3. The Blob: A highly anticipated remake of the 1958 sci-fi horror classic, which Bruckner is currently writing and developing.

His ability to balance these diverse projects indicates a director who is comfortable moving between intimate, character-focused dramas and large-scale, effects-driven creature features—a versatility that the producers of Smile 3 likely view as essential for the franchise’s future.

The Road Ahead

As pre-production on Smile 3 begins, the industry will be watching closely to see how the franchise adapts to a new directorial vision. The challenge for Bruckner will be to honor the established aesthetic—characterized by harsh lighting, disorienting camera angles, and the iconic "smile" imagery—while simultaneously pushing the boundaries of the series.

Parker Finn, meanwhile, continues his tenure at Paramount, where he is currently directing a remake of the classic psychological thriller Possession. With a release date slated for June 11, 2027, and Callum Turner and Margaret Qualley attached to star, Finn’s work remains a cornerstone of the studio’s genre slate.

The transition to Bruckner for the Smile series marks a pivotal moment. The franchise has successfully transitioned from a breakout original hit to a sustainable, multi-film series. By combining the proven, trauma-based narrative framework developed by Finn with the technical expertise and genre-specific sensibilities of Bruckner, Paramount is positioning itself to maintain its foothold in the competitive landscape of modern horror cinema. Whether the third installment will lean into a larger, more sprawling mythology or remain anchored in the intimate, psychological torment of its predecessors remains to be seen, but the industry consensus is clear: the Smile entity is far from finished.